INNT
TOTAL INVALIDATION PROCESSED BY THE IB
02/19/2026
Back to search
Official data from USPTO
PHOENIX RESPIGEN
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
PHOENIX RESPIGEN
ST13
US500000079209457Class
5
Filing
79209457
Registration
5477653
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
32
Latest update
02/20/2026
Trademark type
Word
Nice classes
5
Filing date
02/27/2017
Registration date
05/29/2018
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
12/13/2024
Last transaction
02/20/2026
Responsible office
United States Patent and Trademark Office
Status code
709
Official register
Principal Register
Drawing code
4
Owner type
99
Owner location
DE
Examiner
HAN, DAWN L
Law office
L70
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
PHOENIX PHARMA GMBH - SUCURSAL EM PORTUGAL
Representatives
John Cyril Malloy, III(a member of the Bar of the Malloy & Malloy, P.L.
Technical classification
Nice Classes
Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Dietetic food and substances in the nature of food and beverages adapted for medical use; dietary supplements for humans
Publications
History of USPTO decisions and trademark events.
32 publications found
INTS
TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
01/31/2026
INPC
INVALIDATION PROCESSED
01/31/2026
INTR
TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
08/13/2025
C71T
CANCELLED SECTION 71
12/13/2024
REM3
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
05/29/2023
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
09/28/2018
FICS
FINAL DISPOSITION NOTICE SENT TO IB
09/05/2018
FIMP
FINAL DISPOSITION PROCESSED
09/05/2018
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
08/29/2018
R.PR
REGISTERED-PRINCIPAL REGISTER
05/29/2018
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
03/13/2018
PUBO
PUBLISHED FOR OPPOSITION
03/13/2018
GPNX
NOTIFICATION PROCESSED BY IB
03/09/2018
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
02/21/2018
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
02/21/2018
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
02/21/2018
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
02/02/2018
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
12/28/2017
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
12/28/2017
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
12/28/2017
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
12/27/2017
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
12/27/2017
RFNT
REFUSAL PROCESSED BY IB
07/14/2017
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
06/29/2017
RFRR
REFUSAL PROCESSED BY MPU
06/29/2017
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
06/21/2017
CNRT
NON-FINAL ACTION WRITTEN
06/20/2017
MAFR
APPLICATION FILING RECEIPT MAILED
06/16/2017
DOCK
ASSIGNED TO EXAMINER
06/12/2017
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
06/12/2017
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
06/08/2017
Continuous trademark protection
Get notified about every new filing that threatens PHOENIX RESPIGEN or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.